P
Perinatal HIV Research Unit (PHRU) | Soweto ACTG CRS
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Isoniazid
DLM
Delamanid
Selgantolimod
Rifapentine
INH
Estradiol
Pitavastatin
Parent organization
This site is a part of Perinatal HIV Research Unit (PHRU)
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
2 of 7 total trials
The purpose of this study is to evaluate response to and safety of the HBV vaccine HEPLISAV-B in two study populations living with HIV: prior HBV vac...
Active, not recruiting
HIV Infection
Hepatitis B
Biological: HEPLISAV-B
Biological: ENGERIX-B
The purpose of this study is to compare the efficacy and safety of 26 weeks of delamanid (DLM) versus 26 weeks of isoniazid (INH) for preventing conf...
Enrolling
Tuberculosis, MDR
Dietary Supplement: Pyridoxine (vitamin B6)
Drug: Delamanid (DLM)
Trial sponsors
A
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems